• DOI:10.1007/s11095-020-02849-1
Corpus ID: 219590658

Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls

@article{Cushnie2020BioprospectingFA,
  title={Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls},
  author={T. P. Tim Cushnie and Benjamart Cushnie and J. Echeverria and Winita Fowsantear and Sutthiwan Thammawat and Jolyon L. A. Dodgson and S. Law and Simon M. Clow},
  journal={Pharmaceutical Research},
  year={2020},
  volume={37},
  pages={1-24}
}

T.P. Tim Cushnie, Benjamart Cushnie, +5 authors Simon M. Clow

Published 2020

Business, Medicine

Pharmaceutical Research

Bioprospecting is the exploration, extraction and screening of biological material and sometimes indigenous knowledge to discover and develop new drugs and other products. Most antibiotics in current clinical use (eg. β-lactams, aminoglycosides, tetracyclines, macrolides) were discovered using this approach, and there are strong arguments to reprioritize bioprospecting over other strategies in the search for new antibacterial drugs. Academic institutions should be well positioned to lead the… CONTINUE READING

View on Springer

zenodo.org

Save to Library

Create Alert

Cite

Launch Research Feed